Pelosi’s drug pricing plan puts medical innovation at risk

17 October 2019 - The future of medical innovation in America is at a crossroads. ...

Read more →

Intellectual property law amends will add to business uncertainty

26 July 2019 - Medicines Australia supports efforts to strengthen Australia’s Intellectual Property arrangements to be consistent with international best ...

Read more →

Government to invest £16 million in 'life-saving' medical advances

22 July 2019 - The Government has announced the decision to invest around £16 million in various ‘life-saving’ medical advances, ...

Read more →

How the FDA uses science to speed medical device innovation

11 July 2019 - The MDDT program streamlines the medical device development and review process. ...

Read more →

GSK welcomes the UK trial of subscription-style payment system for pharma companies to incentivise creation of new antibiotics

9 July 2019 - GSK is committed to tackling antimicrobial resistance as part of a sustained, multi-stakeholder response to this global ...

Read more →

UK launches subscription style payment pilot to incentivise pharma antibiotics R&D

9 July 2019 - The UK is to try out a subscription-style payment model aimed at incentivising pharma and biotech ...

Read more →

Innovation prizes to support cell and gene therapy

2 July 2019 - Personalised cell and gene therapy represent a fundamental therapeutic revolution.  ...

Read more →

Rebalancing high prescription drug prices with innovation incentive

1 July 2019 - The current firestorm over high drug prices didn’t start with the May 2019 approval of Novartis’s onasemnogene ...

Read more →

Azar's plan to tie U.S. drug prices to foreign ones will impact investments in R&D

21 June 2019 - Americans, be they Republicans or Democrats, are outraged by the rising cost of prescription drugs.  ...

Read more →

Sustainable discovery and development of antibiotics — is a non-profit approach the future?

19 June 2019 - Shifting to a nonprofit-driven model for development of antibiotics could encourage discovery and development of truly needed ...

Read more →

Drug prices and innovation

20 June  2019 - The crisis in drug pricing has reached global proportions.  ...

Read more →

Economic analysis falls short when it comes to medicines’ value

26 February 2019 - For the past two decades, a plethora of organisations identified by various innocuous acronyms (e.g., NICE) ...

Read more →

New drug landscape dominated by high cost medicines

19 February 2019 - The Patented Medicine Prices Review Board, through the National Prescription Drug Utilization Information System research initiative, ...

Read more →

Quebec appeals court orders province to restore full coverage of rheumatoid-arthritis drug Remicade

13 February 2019 - Quebec’s highest court has ordered the provincial government to restore full public coverage of Remicade, an ...

Read more →

FDA finalises new policy to encourage widespread innovation and development of new buprenorphine treatments for opioid use disorder

6 February 2019 - Today, the U.S. FDA issued a final guidance, “Opioid Use Disorder: Developing Buprenorphine Depot Products for Treatment,” ...

Read more →